Convergent ablation for persistent atrial fibrillation: A UK multicentre perspective

Nilanka N. Mannakkara*, Ibrar Khan, Auns Ghazanfar, Nadeev Wijesuriya, Vishal S. Mehta, Felicity De Vere, Sandra Howell, Shaumik Adhya, Bradley Porter, Nicholas Child, Reza Razavi, Christopher A. Rinaldi, Paolo Bosco, Christopher Blauth, Jaswinder S. Gill

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and remains a major cause of morbidity and mortality. Unfortunately, a significant proportion of patients have persistent AF, for which conventional catheter ablation is less effective. However, convergent ablation has emerged in recent years as a hybrid treatment targeting both the epicardium and endocardium in a multidisciplinary joint cardiothoracic and electrophysiology procedure, with promising efficacy outcomes in recent studies. This treatment is increasingly being performed in the United Kingdom. This review article discusses the rationale and evidence behind convergent ablation, along with factors that need to be considered when setting up a successful ablation service.

Original languageEnglish
Pages (from-to)2039-2052
Number of pages14
JournalJournal of Cardiovascular Electrophysiology
Volume35
Issue number10
DOIs
Publication statusPublished - Oct 2024

Keywords

  • arrhythmia
  • atrial fibrillation
  • catheter ablation
  • hybrid ablation

Fingerprint

Dive into the research topics of 'Convergent ablation for persistent atrial fibrillation: A UK multicentre perspective'. Together they form a unique fingerprint.

Cite this